Act 25 of 2021 (Compliance/Appeals)

Act 25 of 2021 serves as a pivotal modernization of the Pennsylvania Tax Reform Code, establishing a formal appeals process for tax credit determinations while mandating rigorous tax clearance for applicants and their significant owners to ensure comprehensive fiscal compliance. By expanding transparency through mandatory accountability reporting and tightening the oversight of the tax credit brokerage market, the Act integrates the Research and Development (R&D) tax credit into a more disciplined and legally predictable administrative regime.

The enactment of Act 25 of 2021 represents one of the most comprehensive updates to the administrative machinery of the Pennsylvania Department of Revenue since the 1970s. While primarily functioning as an omnibus amendment to the Tax Reform Code of 1971, its implications for the Research and Development tax credit are particularly profound, as it shifts the program from a discretionary award system toward a more robust, rights-based procedural framework. Before this legislation, the mechanisms for challenging Departmental decisions were fragmented and lacked a clear statutory basis for tax credit applicants. Act 25 addresses these deficiencies by codifying the "Application and Administration" of tax credits under Article XVII-A.1, thereby extending the full spectrum of procedural due process to participants in the R&D program. This evolution is not merely a legal technicality; it reflects a broader legislative intent to foster a more stable and predictable environment for corporate innovation within the Commonwealth. By institutionalizing transparency through mandatory reporting and establishing a multi-tiered appeals hierarchy, the Act ensures that the $60 million annual investment in R&D is administered with a level of oversight commensurate with its economic significance.

The Historical Evolution of Innovation Incentives in Pennsylvania

To appreciate the significance of Act 25, one must examine the developmental trajectory of the Pennsylvania Research and Development tax credit. Established by Act 7 of 1997, the credit was originally intended to stimulate high-tech growth by allowing businesses to offset a portion of their qualifying research expenses against state tax liabilities. Initially, the program was relatively modest in its administrative oversight, focusing primarily on the basic eligibility of research activities. However, as the program matured, the General Assembly recognized the need for greater accountability. Act 46 of 2003 expanded reporting requirements to include the names of taxpayers utilizing the credit and the specific amounts approved, marking the first major step toward public transparency.

The subsequent years saw a gradual tightening of fiscal controls. Act 85 of 2016 made the R&D tax credit permanent, removing sunset provisions that had previously cast doubt on the long-term viability of the incentive for capital-intensive industries. This was followed by Act 43 of 2017, which authorized the Department of Revenue to perform tax clearances on applicants—a precursor to the more stringent owner-level compliance checks introduced by Act 25. These incremental changes culminated in the 2021 legislation, which synthesized disparate administrative practices into a unified code of conduct for both the Department and the taxpayer. The historical progression indicates a clear movement from a "trust-based" system of incentives toward a "compliance-first" model that demands rigorous substantiation and legal standing from all participants.

The Statutory Nexus of Act 25: Compliance and Tax Clearance

The most immediate operational change mandated by Act 25 of 2021 is the reinforcement of "tax clearance" as the absolute gateway to incentive eligibility. Under Section 1703-A, the administering agency must make a definitive finding that an applicant has filed all required State tax reports and paid any balance of State tax due before a credit can be awarded. This compliance check is performed at the point of application and serves as a hard filter; failure to satisfy these obligations results in immediate disqualification, regardless of the merits of the research performed.

The 20 Percent Ownership Threshold

Perhaps the most rigorous aspect of the new compliance regime is its extension to significant owners of the applicant entity. Department of Revenue guidance, authorized under the omnibus powers of Act 25, stipulates that any person or business holding a 20 percent or greater ownership interest must pass an individual tax clearance check. This policy is designed to prevent "pass-through" entities from being used as vehicles for tax credits while their principals remain delinquent on personal or other corporate tax obligations.

Ownership Disclosure Requirement	Data Element Needed	Regulatory Justification
Principal Identification	Full Legal Name and Relationship Type	Verification of controlling interest
Federal Identification	SSN for individuals; FEIN for businesses	Linkage to Department tax records
Address Validation	Full legal address (no abbreviations)	System-generated clearance match
Ownership Percentage	Specific stake \(\ge 20\%\)	Determination of "attributable interest"

This requirement places an additional burden of due diligence on tax professionals and corporate officers. They must not only verify the entity's standing but also ensure that all majority shareholders, partners, or members are in good standing with the Commonwealth. The guidance specifically warns that the Department may conduct onsite audits at the physical address provided in the application to verify records and compliance status.

Administrative Procedures for Tax Clearance

The local state revenue office has implemented these mandates through the myPATH online system. The application process begins with an "Entity and Ownership Compliance" phase, where the system cross-references the provided FEINs and SSNs against the Department’s Integrated Tax System. If a discrepancy is found, the application is flagged as "insufficient" under Section 1703-A(a). The law provides that the Department "shall" notify the applicant of such insufficiency, allowing a window for correction. However, revenue office guidance clarifies that if the applicant fails to provide a timely response or fails to cure the tax delinquency, the denial becomes final, triggering the new appeals process established by the Act.

The Procedural Right of Appeal: Level 1 - The Board of Appeals

Before the passage of Act 25, tax credit denials were often viewed as final administrative actions with limited avenues for formal contest. Act 25 fundamentally changes this by establishing that a taxpayer, broker, or the Department has a right to appeal determinations concerning the administration of tax credits and benefits. The first tier of this appellate hierarchy is the Board of Appeals (BOA), an administrative body tasked with reviewing initial actions taken by the Department.

Jurisdiction and Filing Mechanics

The Board of Appeals has jurisdiction over a wide range of R&D-related disputes, including denials based on tax clearance, disputes over the calculation of qualified research expenses (QREs), and disagreements regarding "small business" status. For application year 2021 and subsequent years, the BOA serves as the primary arbiter of these disputes.

The filing of a petition must follow specific procedural guidelines to be considered valid:

• Method of Submission: Petitions must be filed via the Online Petition Center or through United States Mail. The Board explicitly does not accept petitions by email or fax.
• Filing Date Determination: For electronic filings, the timestamp of the submission serves as the filing date, with a deadline of midnight Eastern Time on the final day of the appeal window.
• Representation: A petitioner may appear on their own behalf or be represented by an individual with the "required technical knowledge." There is no strict requirement for legal or accounting licensure, though a written authorization for the representative is mandatory.

Evidentiary Standards and Hearings

The Board of Appeals operates as a quasi-judicial body, reviewing evidence and conducting hearings as necessary to decide the merits of the case. In the context of the R&D credit, this often involves the submission of detailed project logs, payroll records, and federal Form 6765 equivalents to substantiate the research activities conducted within Pennsylvania. The Board is authorized to review whether the Department correctly applied the four-part test for qualified research and whether the proration of credits was executed according to statutory limits.

The Procedural Right of Appeal: Level 2 - The Board of Finance and Revenue

Should a taxpayer remain unsatisfied with the decision rendered by the Board of Appeals, Act 25—in conjunction with the broader procedural updates of the Tax Reform Code—provides for a second level of administrative review at the Board of Finance and Revenue (BFR). The BFR is an independent administrative board within the Treasury Department, providing a check on the Department of Revenue’s decisions.

Evolving Timelines and the BFR Portal

A critical nuance for practitioners is the recent shift in filing timelines. For appeals filed with the BFR on or after January 27, 2025, taxpayers generally have 90 days to file appeals related to certain taxes, but for reviews of BOA decisions regarding tax credit determinations, the window is historically 60 days from the mailing date of the BOA’s decision. The BFR has launched a "Tax Appeal Portal" to streamline this process, allowing for the electronic upload of documents and real-time tracking of the appeal status.

Appeal Component	Specification	Statutory Reference
Review Authority	De novo review of BOA decisions	72 P.S. § 9704
Filing Window	60 days from BOA decision mailing	Act 25 / Procedural Code
Mediation Option	Requestable at no extra cost	BFR Policy
Judicial Escalation	Appealable to Commonwealth Court	Pa.R.A.P.

The BFR also encourages "mediated settlements." This is a significant development for R&D credit disputes, which often involve complex factual disagreements over what constitutes "qualified" research. Mediation allows for a compromise that can resolve the matter more quickly than formal litigation, ensuring that the taxpayer can utilize the credit within a reasonable timeframe.

Local State Revenue Office Guidance: The myPATH Ecosystem

The Pennsylvania Department of Revenue has moved aggressively to digitize the administration of tax credits. Guidance issued by the state revenue office emphasizes that all R&D applications must be submitted through myPATH. This platform is not merely a submission portal; it is an integrated compliance engine that enforces the mandates of Act 25.

Technical Guidance for Applications

The local revenue office provides specific instructions to avoid common "insufficient application" triggers:

1. Identifier Verification: All SSNs and FEINs for owners and officers must be double-checked. Incorrect identifiers will result in a failure of the automated tax clearance process.
2. Narrative Descriptions: Each Pennsylvania-based project must have a detailed description. This is the primary evidence used by the Department to determine if the activities meet the federal definition of qualified research as adopted by Pennsylvania law.
3. Address Standardization: Applicants are instructed to avoid abbreviations in addresses to ensure that the system can properly match records against the Department’s database of tax liens and delinquencies.
4. Small Business Substantiation: Small businesses must attach a balance sheet showing total assets of less than $5 million at the start or end of the year. Failure to provide this documentation will result in the application being processed at the lower 10% credit rate, even if the firm otherwise qualifies.

Direct Communication Channels

To facilitate compliance, the Department has established a specific "subtype" for messages within myPATH: “R&D Tax Credit Application Questions.” Practitioners are encouraged to use this feature for real-time clarification on complex ownership structures or technical qualification issues before the December 1 deadline.

The Secondary Market: Broker Registration and Transferability

Pennsylvania’s R&D tax credit is distinguished by its liquidity. Since 2003, unused credits can be sold or assigned, providing a vital source of capital for pre-revenue startups. Act 25 of 2021 introduced significant new regulations for the "middlemen" in this market.

Strengthening Market Integrity

Under Section 1704-A, the law now mandates the registration of tax credit brokers. This requirement is intended to strengthen the administration of the program and prevent the fraud or abuse that can sometimes occur in the secondary transfer of restricted credits.

The registration process is two-fold:

• Employer Validation: The brokerage firm must validate that it has authorized specific individuals to engage in the sale or assignment of credits.
• Broker Registration: The individual broker must complete an online application, providing personal and professional details. This registration is effective for two years and requires periodic renewal.

Any individual involved in the "business of effectuating transactions in tax credits for the account of others" who fails to register is in violation of the law. This ensures that when an innovative company seeks to sell its credit, it is working with a registered professional subject to Departmental oversight.

Restrictions and Utilization Rules for Buyers

Act 25 also clarifies the rules for those who purchase R&D credits. A purchaser must apply the credit against their tax liability in the taxable year in which the purchase or assignment occurs. There are strict limitations on this utilization:

1. 75 Percent Cap: A purchased credit cannot be used to offset more than 75 percent of the purchaser's total tax liability for that year.
2. No Carryforward: Unlike the original awardee, who can carry the credit forward for up to 15 years, a purchaser must use the credit immediately or lose it.
3. No Resale: The purchase is the final transaction; the buyer cannot further sell or assign the credit to a third party.

These rules ensure that while the credit is transferable, its usage remains focused on the immediate reduction of tax liabilities, thereby encouraging the timely circulation of capital within the Commonwealth's innovation economy.

Transparency and Accountability Reporting Mandates

In a significant expansion of the Department's duties, Act 25 mandates enhanced reporting for all tax credit and benefit programs. This initiative is designed to provide the General Assembly and the Independent Fiscal Office (IFO) with the data necessary to evaluate the economic utility of these incentives.

Annual Departmental Reports

No later than 45 days after the end of a program year, the administering agency must publish a report disclosing:

• The name of every applicant that received a credit.
• The exact amount of the credit awarded.
• Details on the transfer of credits, including the names of the purchasers (for non-individual entities).

The Research and Development tax credit reports have incorporated these "Act 25 requirements" since the October 2023 report cycle. This level of transparency is intended to deter frivolous claims and provide a clear map of which sectors and regions are benefiting most from the Commonwealth’s innovation policy.

The Participant Accountability Report

The burden of transparency does not fall solely on the Department. Under Article XVII-A.1, all participants who receive an R&D tax credit are required to file a "Tax Credit and Tax Benefit Accountability Report". This report must be filed within 45 days of the taxpayer's annual tax return filing. It tracks the specific economic outcomes of the credit, such as:

• Itemization of Pennsylvania-based research expenses.
• Number of jobs created or retained as a result of the research activities.
• The total state taxes paid by the business entity.

Failure to file this report can jeopardize future credit applications, as it is considered a compliance obligation under the broader umbrella of Act 25’s oversight framework.

Quantitative Analysis: Credit Rates, Proration, and Impact

The Pennsylvania R&D tax credit is a finite resource. With an annual program cap of $60 million, the demand for credits frequently exceeds the supply. Act 25 and subsequent updates (such as Act 53 of 2022) have established a structured way to handle this oversubscription.

The Two-Tiered Credit System

Pennsylvania maintains a distinct advantage for small businesses, which are defined as for-profit entities with a net book value of assets less than $5 million.

Business Category	Credit Rate on Excess QREs	Annual Cap Set-Aside
Small Business	20%	$12 Million
"Not Small" Business	10%	$48 Million

The calculation for the "excess" QRE is incremental. A business must first establish its "base amount," which is the greater of the average of its PA QREs from the preceding four years or 50% of its current year PA QREs.

The Reality of Proration

Because all timely applications are reviewed simultaneously after the December 1 deadline, the Department must prorate the awards if total tentative requests exceed the available cap.

In recent years, the proration for "not small" businesses has been significant. For the 2024 awards, for-profit entities that were not classified as small businesses received only 41.1% to 42.1% of their tentative requested credits. Small businesses, however, are often fully funded because their total requests frequently stay within the $12 million set-aside. In 2024, small businesses received 100% of their tentative requests, totaling approximately $7.2 million for 198 applicants.

The impact of the federal Tax Cuts and Jobs Act (TCJA) has also been noted in Departmental reports. Starting in 2022, the federal requirement to amortize R&D expenses under Section 174 rather than expensing them immediately has shifted the timing of QREs, which in turn affects the "tentative" credit amounts calculated for Pennsylvania purposes.

Illustrative Scenario: Compliance Denial and the Path of Appeal

To understand the practical application of Act 25, consider the case of "Vanguard Biotech Partners" (VBP), a Pennsylvania-based research firm.

The Application Phase

In November 2024, VBP submits its R&D tax credit application via myPATH. The firm reports $5,000,000 in current year PA QREs. Its historical four-year average is $3,000,000.

• Base Amount: Greater of $3M or $2.5M (50% of current). Base = $3,000,000.
• Excess QRE: $2,000,000.
• Business Classification: With $12,000,000 in assets, VBP is "not small."
• Tentative Credit: $200,000 (10% of $2M).

The Compliance Trigger

During the processing phase, the Department’s automated clearance system identifies that VBP’s CEO, who owns 30% of the firm, has an unfiled 2022 Pennsylvania Personal Income Tax return and an outstanding liability of $12,000. Additionally, the firm itself has a "Lien" for unpaid Employer Withholding Tax from Q1 2024.

Under the authority of Act 25, the Department issues a notice of denial on April 15, 2025, citing non-compliance of the entity and a 20% owner.

The Administrative Appeal

VBP decides to appeal. Within 60 days of the mailing of the denial, the firm files a petition with the Board of Appeals.

1. Correction of Records: VBP provides evidence that the CEO has since filed the missing return and paid the $12,000 liability in full, including interest.
2. Dispute of Lien: VBP argues that the Employer Withholding Lien was issued in error because the firm had filed an amended return that zeroed out the liability. VBP attaches the stamped amended return and bank records.

The Board of Appeals reviews the evidence. Finding that the owner has cured the delinquency and that the entity lien was based on an administrative error, the BOA issues a Decision and Order in favor of VBP.

The Final Award and Proration

With the compliance hurdle cleared, the Department includes VBP in the final award pool. However, because the "not small" business pool is oversubscribed by more than 2-to-1, the final award is prorated at 42.1%. Instead of the $200,000 tentative credit, VBP receives a final award of $84,200. VBP then utilizes the broker registration program to find a registered broker to sell the credit for cash at 92.9% of its value, providing approximately $78,000 in immediate liquidity for the next phase of its research.

Final Thoughts: Strategic Implications for the Innovation Economy

Act 25 of 2021 marks a new era for Pennsylvania’s innovation incentives, where procedural transparency and rigorous compliance are as critical as the research itself. By codifying the rights of appeal and the standards for tax clearance, the Commonwealth has provided a stable legal framework that protects both the taxpayer’s interests and the public’s fiscal integrity.

The move toward electronic filing through myPATH and the inclusion of 20 percent owners in the clearance process reflects a sophisticated, data-driven approach to tax administration. For businesses, the "meaning" of Act 25 is a dual mandate: the pursuit of scientific breakthrough must be accompanied by impeccable tax governance. As the program continues to operate under a fixed $60 million cap, the efficiency and predictability provided by these administrative reforms will be essential in ensuring that Pennsylvania remains a competitive destination for high-tech investment. The ongoing dialogue between the Department of Revenue’s guidance and the statutory protections of the Tax Reform Code will continue to shape the evolution of the R&D credit, reinforcing its role as a cornerstone of the Commonwealth's economic development strategy.